Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Bayer (BAYA) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Pembrolizumab, Vvd-133214Colorectal AdenocarcinomaPhase IIRecruitingA Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or RectumSep 02, 2026
Metformin, SevabertinibHealthy ParticipantsPhase INot Yet RecruitingPhase 1 Study in Healthy Adults to See How Sevabertinib Changes Metformin Levels in the BodyAug 04, 2026
Nurandociguat Old Tablet - Sd, Nurandociguat New Tablet - Sd, Nurandociguat Old Tablet, Nurandociguat New TabletChronic Kidney DiseasePhase ICompletedA Study to Learn About How a New Nurandociguat Tablet is Absorbed and Processed in the Body Compared to an Old Tablet and How Food Affects the Way the New Tablet is Absorbed and Processed in the BodyJul 17, 2026
Docetaxel, Enzalutamide, Darolutamide, Rinzimetostat, Taxotere, Oric-944Metastatic Castration Resistant Prostate CancerPhase IIIRecruitingA Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)Jun 18, 2026
Aspirin, Bay3389934Drug-Drug InteractionPhase IRecruitingA Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy ParticipantsJun 08, 2026
Bay 3670549Atrial FibrillationPhase IIRecruitingA Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial FibrillationMay 13, 2026
Oxymetazoline Hcl 0.05% Nasal GelNasal Congestion, Nasal ObstructionPhase IICompletedA Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe It Is in Healthy AdultsMay 06, 2026―
Ab-1005Parkinson DiseasePhase IINot Yet RecruitingA Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)Apr 28, 2026
Cetuximab, Bay 3771249Advanced/Metastatic Colorectal AdenocarcinomaPhase IRecruitingA Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D MutationApr 01, 2026
Nitroglycerin Spray, NurandociguatStable Coronary Artery DiseasePhase INot Yet RecruitingA Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery DiseaseFeb 16, 2026

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Bayer AG (DE:BAYA) have in its pipeline
Bayer DE:BAYA is currently developing the following drugs: Pembrolizumab, Vvd-133214, Metformin, Sevabertinib, Nurandociguat Old Tablet - Sd, Nurandociguat New Tablet - Sd, Nurandociguat Old Tablet, Nurandociguat New Tablet, Docetaxel, Enzalutamide, Darolutamide, Rinzimetostat, Taxotere, Oric-944, Aspirin, Bay3389934, Bay 3670549, Oxymetazoline Hcl 0.05% Nasal Gel, Ab-1005, Cetuximab, Bay 3771249, Nitroglycerin Spray, Nurandociguat, Darolutamide, Adt, Acoramidis, Ab-1009, Darolutamide, Valemetostat, Treatment A, Treatment B, Treatment C, Prescriptive Infusion Algorithm, Ab-1005, Bay 3401016, Finerenone, Bay 3389934, Finerenone: Intervention A, Finerenone: Intervention B, Sevabertinib, Bay3723113, Sham Surgery, Bemdaneprocel, Bay 3713372, Bay865028, Medroxyprogesterone Acetate, Bay3389934, Opct-001, Bay2927088, Bay 3547926, Bay 3547922, Acetylsalicylic Acid, Bay3498264, Bay3018250 Dose 1, Bay3018250 Dose 2, Bay3018250 Dose 1, Bay3018250 Dose 2 Infusion, Bay3018250 Dose 2 Injection, Bay3283142, Pembrolizumab, Pemetrexed, Carboplatin, Cisplatin, Bay2927088, Bay3630942, Bay3547922, Aav2-Gdnf Gene Therapy, Control Surgery. These drug candidates are in various stages of clinical development as the company works toward FDA approval.